Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1,3-diphenylbenzene
2. 1,1':3',1''-terphenyl
3. 92-06-8
4. M-diphenylbenzene
5. M-triphenyl
6. Santowax M
7. 1,3-terphenyl
8. Isodiphenylbenzene
9. Meta-terphenyl
10. 1,1'-biphenyl, 3-phenyl-
11. Nsc 6808
12. Benzene, M-diphenyl-
13. Woi2pss0kx
14. 26140-60-3
15. Nsc-6808
16. Dsstox_cid_9117
17. Santowax Om
18. Dsstox_rid_78671
19. Dsstox_gsid_29117
20. Diphenylbenzene
21. Terbenzene
22. Santowax R
23. 3-phenylbiphenyl
24. Delowax S
25. Delowax Om
26. Cas-92-06-8
27. Gilotherm Om 2
28. Ccris 1656
29. Hsdb 2537
30. Unii-woi2pss0kx
31. Einecs 202-122-1
32. Ai3-00860
33. Einecs 247-477-3
34. M-terphenyl, 99%
35. 1,3-diphenyl-benzene
36. 1, 3-phenyl-
37. Ai3-01405
38. Terphenyl, M-
39. Unii-lfx1c55d2z
40. 3-phenyl-1,1'-biphenyl
41. Lfx1c55d2z
42. 1,1':3',1''-biphenyl
43. Chembl3184163
44. Dtxsid2029117
45. M-terphenyl, Analytical Standard
46. Nsc6808
47. Zinc1866998
48. Tox21_201579
49. Tox21_303528
50. Mfcd00003059
51. Akos002386404
52. Cs-w010375
53. Ncgc00249075-01
54. Ncgc00257320-01
55. Ncgc00259128-01
56. As-19308
57. Db-079227
58. Ft-0629010
59. G 340
60. T0018
61. Ec 247-477-3
62. T 3009
63. J-503715
64. Q20965190
Molecular Weight | 230.3 g/mol |
---|---|
Molecular Formula | C18H14 |
XLogP3 | 5.6 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 0 |
Rotatable Bond Count | 2 |
Exact Mass | 230.109550447 g/mol |
Monoisotopic Mass | 230.109550447 g/mol |
Topological Polar Surface Area | 0 Ų |
Heavy Atom Count | 18 |
Formal Charge | 0 |
Complexity | 208 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
2 TO 3. 2= SLIGHTLY TOXIC: PROBABLE ORAL LETHAL DOSE (HUMAN) 5-15 G/KG, BETWEEN 1 PINT & 1 QT FOR 70 KG PERSON (150 LB). 3= MODERATELY TOXIC: PROBABLE ORAL LETHAL DOSE (HUMAN) 0.5-5 G/KG, BETWEEN 1 OZ & 1 PINT (OR 1 LB) FOR 70 KG PERSON (150 LB). /TERPHENYL/
Gosselin, R.E., H.C. Hodge, R.P. Smith, and M.N. Gleason. Clinical Toxicology of Commercial Products. 4th ed. Baltimore: Williams and Wilkins, 1976., p. II-105
Depending on the extent to which these compounds are absorbed, the various terphenyls were metabolized to glucuronic acid conjugates and phenol and excreted in the urine of treated rabbits. Following a single 1 gram oral dose of o-, m-, or p-terphenyl, 60% of the o-, 38% of the m-, and a trace of p-terphenyl were detected as their respective glucuronides in the urine. Zero, 15%, and 30% of the o-, m-, and p-terphenyls, respectively, were isolated unchanged in feces.
American Conference of Governmental Industrial Hygienists, Inc. Documentation of the Threshold Limit Values and Biological Exposure Indices. 6th ed. Volumes I, II, III. Cincinnati, OH: ACGIH, 1991., p. 1500
ABOUT THIS PAGE
91
PharmaCompass offers a list of 1,3-Diphenylbenzene API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right 1,3-Diphenylbenzene manufacturer or 1,3-Diphenylbenzene supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred 1,3-Diphenylbenzene manufacturer or 1,3-Diphenylbenzene supplier.
PharmaCompass also assists you with knowing the 1,3-Diphenylbenzene API Price utilized in the formulation of products. 1,3-Diphenylbenzene API Price is not always fixed or binding as the 1,3-Diphenylbenzene Price is obtained through a variety of data sources. The 1,3-Diphenylbenzene Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 1,3-Diphenylbenzene manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 1,3-Diphenylbenzene, including repackagers and relabelers. The FDA regulates 1,3-Diphenylbenzene manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 1,3-Diphenylbenzene API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 1,3-Diphenylbenzene supplier is an individual or a company that provides 1,3-Diphenylbenzene active pharmaceutical ingredient (API) or 1,3-Diphenylbenzene finished formulations upon request. The 1,3-Diphenylbenzene suppliers may include 1,3-Diphenylbenzene API manufacturers, exporters, distributors and traders.
1,3-Diphenylbenzene Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 1,3-Diphenylbenzene GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 1,3-Diphenylbenzene GMP manufacturer or 1,3-Diphenylbenzene GMP API supplier for your needs.
A 1,3-Diphenylbenzene CoA (Certificate of Analysis) is a formal document that attests to 1,3-Diphenylbenzene's compliance with 1,3-Diphenylbenzene specifications and serves as a tool for batch-level quality control.
1,3-Diphenylbenzene CoA mostly includes findings from lab analyses of a specific batch. For each 1,3-Diphenylbenzene CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
1,3-Diphenylbenzene may be tested according to a variety of international standards, such as European Pharmacopoeia (1,3-Diphenylbenzene EP), 1,3-Diphenylbenzene JP (Japanese Pharmacopeia) and the US Pharmacopoeia (1,3-Diphenylbenzene USP).